TACSTD2 and cancer: Downregulation of TROP2 through the generation of small hairpin RNA targeting TROP2 also decreased the invasion ability of the TNBC cell line, suggesting that antigen downregulation in response to TROP2 ADC treatment could potentially impair cancer cells (29).